Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

BUY
$79.4 - $116.36 $45,099 - $66,092
568 Added 4.86%
12,263 $978,000
Q1 2022

Apr 19, 2022

BUY
$86.42 - $109.81 $74,148 - $94,216
858 Added 7.92%
11,695 $1.23 Million
Q4 2021

Feb 02, 2022

BUY
$98.56 - $119.91 $149,811 - $182,263
1,520 Added 16.31%
10,837 $1.17 Million
Q3 2021

Dec 08, 2021

BUY
$91.91 - $110.37 $856,325 - $1.03 Million
9,317 New
9,317 $1.02 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Jb Capital LLC Portfolio

Follow Jb Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jb Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jb Capital LLC with notifications on news.